> the actionable medical returns have been relatively tiny and industry continues to not invest in sequencers for a good reason I agree with this, but I disagr

> the actionable medical returns have been relatively tiny and industry continues to not invest in sequencers for a good reason I agree with this, but I disagree with the following: > most of the progress did NOT come from HGP data. Without HGP (Human Genome Project), many biological discoveries in the past two decades would have become much more difficult. > it's a huge waste of investment until we understand the multigenicity of diseases better If you don't invest, you will never approach a solution. Applied science goes nowhere without a solid foundation in basic science.